Recall: DBL Vancomycin 500 mg injection vial, concerns about decreased potency

A recall has been issued for batches J036913AA & J036913BA of DBL Vancomycin (vancomycin hydrochloride) 500 mg powder for injection vials due to out of specification of specificity stability results which do not meet the shelf-life specification for potency or have atypically declining potency over the 30-month product shelf-life.

Pfizer has asked customer to:

• Inspect and quarantine all units of DBL Vancomycin (vancomycin hydrochloride) 500 mg powder for injection vials with batch numbers mentioned above.
• Return the affected stock to their wholesaler for credit.
• If any recalled stock has been transferred from another facility, to immediately notify them of urgent recall.